论文部分内容阅读
国外采用溶栓酶类药物治疗急性心肌梗塞已取得一定疗效,国内亦已有应用。现就有关内容综述如下。一、溶栓酶类药物及其作用机制血栓或血凝块经激活的纤溶系统使纤维蛋白溶解为纤维蛋白降解产物(FDP),从而消除血栓.这一过程包括:(1)纤溶酶原被激活而成纤溶酶;(2)纤溶酶使纤维蛋白或纤维蛋白原降解成 FDP。FDP 具抗凝血酶的作用及抑制纤维蛋白的聚合;还可阻止血小板的粘着和聚集。故 FDP
Foreign use of thrombolytic drugs in the treatment of acute myocardial infarction has achieved some efficacy, has also been applied. The relevant content is summarized below. First, the thrombolytic drugs and its mechanism Thrombus or blood clot activated by the fibrinolytic system of fibrin degradation products (FDP), thereby eliminating the thrombus.This process includes: (1) plasmin Was originally activated plasmin; (2) plasmin fibrinogen or fibrinogen degradation into FDP. FDP with antithrombin effect and inhibit the polymerization of fibrin; also prevent platelet adhesion and aggregation. Therefore FDP